Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,134 recalls, newest first

Class I · High risk

Cummor Natural Male Enhancement

Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin

Terminated Chemical / undeclared Organic Herbal Supply D-0962-2017
Class II · Moderate risk

Vitamin D3 in Olive Oil Sdv 100

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0786-2017
Class II · Moderate risk

Vitamin D3 in Olive Oil Sdv 100

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0785-2017
Class II · Moderate risk

Vitamin B Complex 1ml Sdv Na Inj

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0784-2017
Class II · Moderate risk

Testost Aq Mdv 50mg/Ml Inj

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0783-2017
Class II · Moderate risk

Sod Phenylbutyrate Sdv 30ml

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0781-2017
Class II · Moderate risk

Sodium Bicarb 50ml Mdv 8.4%

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0778-2017
Class II · Moderate risk

Procaine HCL Sdv 2% Inj

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0774-2017
Class II · Moderate risk

Procaine HCL Sdv 1% Inj

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0773-2017
Class II · Moderate risk

Procaine HCL 50ml Mdv

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0771-2017

Recalls by year